William D. Tap
Active 1995–2025
- 163
- Papers
- 23,412
- Citations
- 75
- h-index
- 152
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine70.3%
- Biochemistry, Genetics and Molecular Biology19.4%
- Immunology and Microbiology6.3%
- Neuroscience1%
- Engineering0.6%
- Computer Science0.5%
- Other1.9%
Topics
- Cancer Immunotherapy and Biomarkers7.9%
- Sarcoma Diagnosis and Treatment7.5%
- Cancer Genomics and Diagnostics3.6%
- CAR-T cell therapy research3.4%
- Immunotherapy and Immune Responses3.1%
- Ferroptosis and cancer prognosis2.3%
- Other72.2%
Coauthors
- Cristina R. Antonescu52
- Sandra P. D’Angelo42
- Mrinal M. Gounder34
- Samuel Singer34
- Mark A. Dickson33
- Ping Chi33
- Ciara M. Kelly23
- Li‐Xuan Qin23
- Evan Rosenbaum22
- Andrew J. Wagner21
- Mary Louise Keohan21
- Robin L. Jones20
- Sujana Movva19
- Gary K. Schwartz17
- John H. Healey17
- Silvia Stacchiotti17
- Suzanne George17
- Aimeé M. Crago16
- Benjamin A. Nacev16
- Hans Gelderblom16
- Javier Martín‐Broto14
- Josephine K. Dermawan14
- Piotr Rutkowski13
- Sebastian Bauer13
All papers
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Authors: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358
- Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Mark T.A. Donoghue, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. Iacobuzio–Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663
- Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Authors: Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean‐Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine - The Lancet 2024 cited by 263
- Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
Authors: Sandra P. D’Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, James N. Atkins, Mohammed Milhem, Balkrishna Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher - The Lancet Oncology 2018 cited by 748
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
Authors: William D. Tap, Hans Gelderblom, Emanuela Palmerini, Jayesh Desai, Sebastian Bauer, Jean‐Yves Blay, Thierry Alcindor, Kristen N. Ganjoo, Javier Martín‐Broto, Christopher W. Ryan, David M. Thomas, Charles Peterfy, John H. Healey, Michiel A. J. van de Sande, Heather L. Gelhorn, Dale E. Shuster, Qiang Wang, Antoine Yver, Henry H. Hsu, Paul Lin, Sandra Tong-Starksen, Silvia Stacchiotti, Andrew J. Wagner - The Lancet 2019 cited by 474
- Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
Authors: William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang, John H. Healey, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Arun S. Singh, Igor Puzanov, Eunice L. Kwak, Andrew J. Wagner, Daniel D. Von Hoff, Glen J. Weiss, Ramesh K. Ramanathan, Jiazhong Zhang, Gaston Habets, Ying Zhang, Elizabeth A. Burton, Gary C. Visor, Laura Sanftner, Paul Severson, Hoa Nguyen, Marie J. Kim, Adhirai Marimuthu, Garson Tsang, Rafe Shellooe, C. M. Gee, Brian L. West, Peter Hirth, K. B. Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul Lin, Sandra Tong-Starksen, Gideon Bollag - New England Journal of Medicine 2015 cited by 582
- Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Authors: Benjamin A. Nacev, Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi, Cerise Tang, Nicholas D. Socci, Satshil Rana, Rodrigo Gularte‐Mérida, Ahmet Zehir, Mrinal M. Gounder, Timothy G. Bowler, Anisha Luthra, Bhumika Jadeja, Azusa Okada, Jonathan A. Strong, Jake Stoller, Jason E. Chan, Ping Chi, Sandra P. D’Angelo, Mark A. Dickson, Ciara M. Kelly, Mary Louise Keohan, Sujana Movva, Katherine A. Thornton, Paul A. Meyers, Leonard H. Wexler, Emily K. Slotkin, Julia Glade Bender, Neerav Shukla, Martee L. Hensley, John H. Healey, Michael P. LaQuaglia, Kaled M. Alektiar, Aimeé M. Crago, Sam S. Yoon, Brian R. Untch, Sarah Chiang, Narasimhan P. Agaram, Meera Hameed, Michael F. Berger, David B. Solit, Nikolaus Schultz, Marc Ladanyi, Samuel Singer, William D. Tap - Nature Communications 2022 cited by 211
- CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Authors: Mary E. Klein, Marta Kovatcheva, Lara E. Davis, William D. Tap, Andrew Koff - Cancer Cell 2018 cited by 393
- Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology
Authors: Manali I. Patel, Ana María López, William Blackstock, Katherine E. Reeder‐Hayes, E. Allyn Moushey, Jonathan Phillips, William D. Tap - Journal of Clinical Oncology 2020 cited by 329
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma
Authors: Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant, Donna Bernstein, John Glod, Rosandra N. Kaplan, Stephan A. Grupp, William D. Tap, Karen Chagin, Gwendolyn K. Binder, Samik Basu, Daniel E. Lowther, Ruoxi Wang, Natalie Bath, Alex J. Tipping, Gareth Betts, Indu Ramachandran, Jean‐Marc Navenot, Hua Zhang, Daniel K. Wells, Erin Van Winkle, Gabor Kari, Trupti Trivedi, Tom Holdich, Lini Pandite, Rafael G. Amado, Crystal L. Mackall - Cancer Discovery 2018 cited by 435
- Sorafenib for Advanced and Refractory Desmoid Tumors
Authors: Mrinal M. Gounder, Michelle R. Mahoney, Brian A. Van Tine, Vinod Ravi, Steven Attia, Hari A. Deshpande, Abha A. Gupta, Mohammed Milhem, Robert M. Conry, Sujana Movva, Michael J. Pishvaian, Richard F. Riedel, Tarek Sabagh, William D. Tap, Natally Horvat, Ethan Basch, Lawrence H. Schwartz, Robert G. Maki, Narasimhan P. Agaram, Robert A. Lefkowitz, Yousef Mazaheri, Rikiya Yamashita, John J. Wright, Amylou C. Dueck, Gary K. Schwartz - New England Journal of Medicine 2018 cited by 449
- Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
Authors: Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis, Anita Krishnan, Jessica Lee, Steven Attia, Wassim Abida, Alexander Drilon, Ping Chi, Sandra P. D’ Angelo, Mark A. Dickson, Mary Lou Keohan, Ciara M. Kelly, Mark Agulnik, Sant P. Chawla, Edwin Choy, Rashmi Chugh, Christian F. Meyer, Parvathi A. Myer, Jessica L. Moore, Ross A. Okimoto, Raphael E. Pollock, Vinod Ravi, Arun S. Singh, Neeta Somaiah, Andrew J. Wagner, John H. Healey, Garrett M. Frampton, Jeffrey M. Venstrom, Jeffrey S. Ross, Marc Ladanyi, Samuel Singer, Murray F. Brennan, Gary K. Schwartz, Alexander J. Lazar, David M. Thomas, Robert G. Maki, William D. Tap, Siraj M. Ali, Dexter X. Jin - Nature Communications 2022 cited by 193
- The epigenomics of sarcoma
Authors: Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, Jamie Yu, C. David Allis, William D. Tap, Marc Ladanyi, Torsten O. Nielsen - Nature reviews. Cancer 2020 cited by 208
- PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
Authors: William Lee, Sewit Teckie, Thomas Wiesner, Leili Ran, Carlos Prieto‐Granada, Mingyan Lin, Sinan Zhu, Zhen Cao, Yupu Liang, Andrea Sboner, William D. Tap, Jonathan A. Fletcher, Kety Huberman, Li-Xuan Qin, Agnès Viale, Samuel Singer, Deyou Zheng, Michael F. Berger, Yu Chen, Cristina R. Antonescu, Ping Chi - Nature Genetics 2014 cited by 633
- Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
Authors: Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, RuRu Chun-Ju Chiang, George D. Demetri, Elisabeth G. Demicco, Jayesh Desai, Mikael Eriksson, Hans Gelderblom, Suzanne George, Mrinal M. Gounder, Alessandro Gronchi, Abha A. Gupta, Rick L. Haas, Andrea Hayes‐Jardon, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugene S. Kleinerman, Axel Le Cesne, Jiwon Lim, María Dolores Chirlaque López, Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 cited by 227
- Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. lacobuzio-Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 cited by 69
- Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
Authors: Ciara M. Kelly, Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Reena Dholakia, Hamza Ahmad, Matthew D. Biniakewitz, Mercedes M. Condy, Haley T. Phelan, Margaret K. Callahan, Phillip Wong, S. J. Singer, Charlotte E. Ariyan, Edmund K. Bartlett, Aimeé M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Li‐Xuan Qin, William D. Tap, Sandra P. D’Angelo - JAMA Oncology 2020 cited by 205
- Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas
Authors: William D. Tap, Andrew J. Wagner, Patrick Schöffski, Javier Martín‐Broto, Anders Krarup‐Hansen, Kristen N. Ganjoo, Chueh‐Chuan Yen, Albiruni R. Abdul Razak, Alexander I. Spira, Akira Kawai, Axel Le Cesne, Brian A. Van Tine, Yoichi Naito, Se Hoon Park, А. А. Феденко, Zsuzsanna Pápai, Victoria Soldatenkova, Ashwin Shahir, Gary Mo, Jennifer Wright, Robin L. Jones, for the ANNOUNCE Investigators - JAMA 2020 cited by 301
- Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
Authors: Michael C. Heinrich, Robin L. Jones, Margaret von Mehren, Patrick Schöffski, César Serrano, Yoon‐Koo Kang, Philippe A. Cassier, Olivier Mir, Ferry A.L.M. Eskens, William D. Tap, Piotr Rutkowski, Sant P. Chawla, Jonathan C. Trent, Meera Tugnait, Erica N Evans, Tamieka Lauz, Teresa Zhou, Maria Roche, Beni B. Wolf, Sebastian Bauer, Suzanne George - The Lancet Oncology 2020 cited by 304
- Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
Authors: William D. Tap, Zsuzsanna Pápai, Brian A. Van Tine, Steven Attia, Kristen N. Ganjoo, Robin L. Jones, Scott M. Schuetze, Damon R. Reed, Sant P. Chawla, Richard F. Riedel, Anders Krarup‐Hansen, Maud Toulmonde, Isabelle Ray‐Coquard, Peter Hohenberger, Giovanni Grignani, Lee D. Cranmer, Scott H. Okuno, Mark Agulnik, William L. Read, Christopher W. Ryan, Thierry Alcindor, Xavier F Garcia del Muro, G. Thomas Budd, Hussein A. Tawbi, Tillman Pearce, Stew Kroll, Denise K. Reinke, Patrick Schöffski - The Lancet Oncology 2017 cited by 306
- Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
Authors: William D. Tap, Víctor M. Villalobos, Gregory M. Coté, Howard A. Burris, Filip Jankú, Olivier Mir, M. Beeram, Andrew J. Wagner, Liewen Jiang, Bin Wu, Sung Choe, Katharine Yen, Camelia Gliser, Bin Fan, Sam Agresta, Shuchi S. Pandya, Jonathan C. Trent - Journal of Clinical Oncology 2020 cited by 156
- Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement
Authors: Edward S. Kim, Thomas S. Uldrick, Caroline Schenkel, Suanna S. Bruinooge, R. Donald Harvey, Allison Magnuson, Alexander I. Spira, James L. Wade, Mark Stewart, Diana Merino Vega, Julia A. Beaver, Andrea Denicoff, Gwynn Ison, S. Percy Ivy, Suzanne George, Raymond P. Perez, Patricia A. Spears, William D. Tap, Richard L. Schilsky - Clinical Cancer Research 2021 cited by 111
- Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Authors: Merry Jennifer Markham, KERRI WACHTER, Neeraj Agarwal, Monica M. Bertagnolli, Susan M. Chang, William Dale, Catherine Diefenbach, Carlos Rodríguez‐Galindo, Daniel J. George, Timothy D. Gilligan, R. Donald Harvey, Melissa L. Johnson, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Robert G. Maki, Jane Meisel, Jeffrey A. Meyerhardt, Nathan A. Pennell, Gabrielle B. Rocque, Michael S. Sabel, Richard L. Schilsky, Bryan J. Schneider, William D. Tap, Robert G. Uzzo, Shannon N. Westin - Journal of Clinical Oncology 2020 cited by 169
- A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Authors: Ciara M. Kelly, Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Benjamin A. Nacev, Evan Rosenbaum, Travis E. Adamson, Samuel Singer, Edmund K. Bartlett, Aimeé M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Cristina R. Antonescu, William D. Tap, Sandra P. D’Angelo - Clinical Cancer Research 2023 cited by 69
